Article - Issue 55
Predictive AI and ML Models in Drug Development
Article - Issue 55
GenAI's Impact on Reshaping the Pharma Industry
Article - Issue 55
The AI Revolution in Pharma
Article - Issue 55
Eli Lilly and Company has partnered with OpenAI to leverage OpenAIs generative AI technology for developing new antimicrobial treatments to combat drugresistant pathogens Antimicrobial resistance
Shanghai Junshi Biosciences Co Ltd a leading biopharmaceutical company focused on innovation has received approval from Chinas National Medical Products Administration
Porton Advanced has recently integrated the MaxCyte cGMPgrade ExPERT GTx Flow Electroporation instrument into its cell therapy platform making it the first cell therapy CDMO in China
ILiAD Biotechnologies LLC a biotechnology company focused on combating diseases caused by Bordetella
Biond Biologics Ltd a clinicalstage biopharmaceutical company specializing in cancer immunotherapy has initiated its firstinhuman clinical trial of BND a humanized ILTLILRB antagonist antibody The trial commenced with the dosing of its first patient at the Institute of Oncology Davidoff Center Rabin...
GSK plc announced today that Omjjara has received approval from Japans Ministry of Health Labour and Welfare for treating myelofibrosis Omjjara is an oral inhibitor of JAKJAK and activin A receptor type
Hyundai Bioscience which is preparing for a dengue fever basket clinical trial in Brazil announced on the th that it has successfully developed a multitreatment drug for mosquitoborne viral infections
Capricor Therapeutics a biotechnology company developing transformative cell and exosomebased therapeutics for the treatment of rare diseases today announced
Charles River Laboratories International Inc and the Gates Institute at the University of Colorado Anschutz Medical Campus today announced a lentiviral vector contract development and manufacturing
BioAI an emerging biotech company applying multimodal artificial intelligence to novel biomarker
Bota Bio a global industrial biotechnology company specializing in sustainable biomanufacturing solutions and NHU a global leader in the fine chemical industry have announced the successful commercialization
Sun Pharmaceutical Industries Limited today announced the successful completion of the merger of Taro Pharmaceutical Industries Ltd with its subsidiary As part of this merger Sun Pharma acquired all outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or its affiliate...
Incheon, South Korea
Suntec Convention & Exhibition Centre, Singapore
Basel, Switzerland
Boston, MA, USA
Singapore
Tokyo, Japan
Boston, MA, USA
Jakarta Barat, Indonesia
Senior Researcher and Head of Innovative Product Development, Jotbody (HK) Limited
R&D Lead, Jotbody (HK) Limited
Senior Industry Analyst, Healthcare and Life Sciences, Frost & Sullivan.
Department of Engineering Science, University of Oxford.
Assistant Manager - Medical Affairs and Pharmacovigilance, Unichem Laboratories Ltd.
Professor, Chuo University
Assistant Professor, King Abdulaziz University
President
Asia has had a dramatic spike in interest for medical research pharma advancement and global investment China and India are emerging as leaders in clinical trials They recruit patients faster cheaper and are better than Europe South America or the US because the economies are encouraging more researchMycobacterium tuberculosis Mtbis one of the major infectious diseases posing a major threat to many developing countries including India It has been a daunting task for researchers and scientists to design and develop drugs that possess the potential to inhibit the disease in a specific manner without exhibiting side effects in humans Presently there are four drugs
The cellular proteinprotein interaction network that governs cellular proliferation cell cycle is highly complex Here we have developed a novel computational model of human mitotic cell cycle integrating diverse cellular mechanisms
AbstractBackgroundSlow and cumbersome laboratory diagnostics for Mycobacterium tuberculosis complex MTBC risk delayed treatment and poor patient outcomes Wholegenome sequencing WGS could potentially provide a rapid and comprehensive diagnostic solution In this prospective study we compare realtime
Iovance Biotherapeutics has developed firstofitskind AMTAGVI cell therapy for a solid tumour cancer and first treatment option for advanced melanoma
Global Supply Chain Trends Overview This report highlights the results from PRTMs sixth annual survey of global supply chain trends The survey is designed to provide critical insight into how industry leaders are globalizing their supply chain operations to achieve competitive advantage in todays challenging business environment
Approximately million people worldwide are living with a rare disease and about half of those affected by rare diseases are children
Although less well known than other drug development phases human factors engineering HFE is critical to meeting regulatory expectations for drugdevic...
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Many advanced largescale AI initiatives still need to be proved successful in Pharma
Singapore has had a multidecade longterm vision for building a worldclass biomedical cluster
